Angiopeptin-eluting stents: Observations in human vessels and pig coronary arteries

Journal of Invasive Cardiology

Volumn 14, Issue 5, 2002, Pages 230-237

  Armstrong, Johanna ^a   Gunn, Julian ^a   Arnold, Nadine ^a   Malik, Nadim ^a   Chan, K H ^a   Vick, Terry ^a   Stratford, Peter ^a   Cumberland, David C ^a   Holt, Cathy M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Coronary disease; Pharmacokinetics; Restenosis; Smooth muscle; Stents

Indexed keywords

ANGIOPEPTIN; PHOSPHORYLCHOLINE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN TISSUE; KINETICS; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; POSTOPERATIVE COMPLICATION; RESTENOSIS; SAFETY; SMOOTH MUSCLE FIBER; SWINE;

ANIMALS; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY VESSELS; HUMANS; IODINE RADIOISOTOPES; OLIGOPEPTIDES; PHOSPHORYLCHOLINE; SAPHENOUS VEIN; SOMATOSTATIN; STENTS; SWINE; TUNICA INTIMA;

EID: 0036255506     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary disease
2. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
3. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis
4. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study
5. Low molecular weight heparin in prevention of restenosis after angioplasty. Results of enoxoparin restenosis (ERA) trial
6. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery
7. A dual purpose angioplastydrug infusion catheter for the treatment of intragraft thrombus
8. Local infusion balloon angioplasty to obviate restenosis compared with conventional balloon angioplasty in an experimental model of atherosclerosis
9. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons
10. Is local drug delivery truly a low efficiency procedure?
11. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons
12. Antithrombotic potential of polymer coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody
13. In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents
14. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis
15. The RAVEL study: A randomized study with the sirolimus coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions
16. Novel drug-delivery stent. Intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system
17. Early inhibition of myointimal proliferation by angiopeptin after balloon injury in the rabbit
18. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries
19. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty
20. Disposition and tissue distribution of angiopeptin in the rat
21. The effect of porous balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit
22. Local angiopeptin delivery using coated stents reduces neointimal proliferation in overstretched porcine coronary arteries
23. Biocompatible surfaces using methacryloylphosphorylcholine lauryhnethacrylate copolymer
24. Phosphorylcholine-a biocompatible coating for coronary angioplasty devices
25. Phosphorylcholine coated metallic stents in rabbit iliac and porcine coronary arteries
26. The analysis of post implant phosphorylcholine coatings on cardiovascular stents by AFM
27. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model
28. Intravascular stents: A new technique for tissue processing for histology, immunohistochemistry and transmission electron microscopy
29. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
30. Angiopeptin enhances acetylcholine-induced relaxation and inhibits intimal hyperplasia after vascular injury
31. Sustained suppression of neointimal proliferation by sirolimus-eluting stents
32. Sustained local delivery of dexamethasone by a novel intravascular cluting stent to prevent restenosis in the porcine coronary injury model
33. Effect on intimal hyperplasia of dexamethasone from coated metal stents compared with non-coated stents in canine femoral arteries
34. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: Comparative study of two drugs
35. Localised arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution and bioactivity of forskolin
36. Phosphorylcholine-coated stents in porcine coronary arteries: In vivo assessment of biocompatibility
37. Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries
38. Pharmacologic studies of somatostatin and somatostatin analogues: Therapeutic advances and perspectives
39. Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo
40. Inhibition of myointimal proliferation of the rat carotid artery by the peptides angiopeptin and BIM 23034
41. Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation
42. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells
43. Angiopeptin: A treatment for accelerated myointimal hyperplasia